Supplemental material
OncoImmunology
Volume 8, 2019 - Issue 2
Related Research Data
Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired.
Source:
American Society of Hematology
Chemokines
Source:
American Society of Hematology
The genetics of hereditary colon cancer
Source:
Cold Spring Harbor Laboratory
Cytokine Levels in the Serum of Healthy Subjects
Source:
Hindawi Limited
V gamma 9V delta 2 T lymphocytes efficiently recognize and kill zoledronate-sensitized, imatinib-sensitive, and imatinib-resistant chronic myelogenous leukemia cells.
Source:
The American Association of Immunologists
Pembrolizumab in patients (pts) with PD-L1–positive (PD-L1+) advanced ovarian cancer: Updated analysis of KEYNOTE-028.
Source:
American Society of Clinical Oncology (ASCO)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
Source:
Massachusetts Medical Society
A Gynecologic Oncology Group study
Source:
Wiley
Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer
Source:
American Society of Clinical Oncology (ASCO)
Dose-Response Association of CD8(+) Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
Source:
American Medical Association (AMA)
The immune contexture in human tumours: impact on clinical outcome
Source:
Springer Science and Business Media LLC
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection (DOI:10.1016/j.immuni.2007.09.006)
Source:
Elsevier BV
Regulation of Cutaneous Malignancy by γδ T Cells
Source:
American Association for the Advancement of Science (AAAS)
Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors
Source:
American Association for Cancer Research (AACR)
Interlesional diversity of T cell receptors in melanoma with immune checkpoints enriched in tissue-resident memory T cells.
Source:
American Society for Clinical Investigation
Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells.
Source:
American Association for the Advancement of Science (AAAS)
Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer
Source:
American Association for Cancer Research (AACR)
Immunological Profiling of Prostate Tissue
Source:
Wiley
T cell exhaustion
Source:
Springer Science and Business Media LLC
Clinical outcomes and prognostic factors of patients with epithelial ovarian cancer subjected to first-line treatment: a retrospective study of 251 cases
Source:
Springer Science and Business Media LLC
γδ T Cells Provide an Early Source of Interferon γ in Tumor Immunity
Source:
Rockefeller University Press
Targeting T Cell Co-receptors for Cancer Therapy
Source:
Elsevier BV
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
Source:
Proceedings of the National Academy of Sciences
Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer
Source:
Informa UK Limited
Investigation of the freely available easy-to-use software 'EZR' for medical statistics.
Source:
Springer Science and Business Media LLC
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Source:
Massachusetts Medical Society
Tumor-infiltrating NY-ESO-1–specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer
Source:
Proceedings of the National Academy of Sciences
Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD-1 and Low Levels of CD127 Expression
Source:
American Society for Microbiology
CD8+ T Cells Specific for Tumor Antigens Can Be Rendered Dysfunctional by the Tumor Microenvironment through Upregulation of the Inhibitory Receptors BTLA and PD-1
Source:
American Association for Cancer Research (AACR)
Linking provided by
